ArticleJournal of the International AIDS Society2016

Long-term effectiveness of initiating non-nucleoside reverse transcriptase inhibitor- versus ritonavir-boosted protease inhibitor-based antiretroviral therapy: implications for first-line therapy choice in resource-limited settings.

Viviane D Lima et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.